SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.

ABSTRACT:

SUBMITTER: Kreuzberger N 

PROVIDER: S-EPMC8411904 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature